BackTable Tumor Board

Gear up for BackTable Tumor Board Season 2: Genitourinary (GU) Cancer! 🚀Launch day is May 27! 🎧11 total in-depth episodes 🔬Multidisciplinary experts from #UroOnc, #MedOnc, #RadOnc, etc. @RichMatulewicz @nabiladra @virajmaster @BogdanaSchmidt @apolo_andrea @pjhensley11

Are there better intravesical options than BCG? This week, Dr. Lindsey Herrell from @UMichUrology joins @RuchikaTalwarMD to explore therapies for intermediate risk #bladdercancer. #ONC19 @wandering_gu @BenPockros @theusinghal @stensy @angiesmith_uro open.spotify.com/episode/3vekb1…

This week on BT ONC: @RuchikaTalwarMD and @KKBree discuss the various treatment options for intermediate-risk #NMIBC. #ONC18 #bladdercancer @MDAndersonNews @UCSDUrology @VUMCUrology @ASCO @UroGenPharma @UroDocAsh @tompowles1 @shilpaonc @BladderCancerUS open.spotify.com/episode/1nat9E…

🎉 We made the list! Our FREE CME on Combination Therapies for HCC just hit the Top 20 on myCME. Join thousands of peers advancing liver cancer care - and earn credit while you do it! ➡️ Enroll now: plus.backtable.com/courses/Multid… #CME #MedEd

This week on BT Tumor Board: Episode 17 focuses on #penilecancer diagnosis and treatment, featuring #UroOnc Dr. Charles Peyton, #RadOnc Dr. Juanita Crook, and #MedOnc Dr. Andrea Apolo. #ONC17 @apolo_andrea @UABUrology @GTumorBoard @ASCO open.spotify.com/episode/688Njo…

In Ep. 16, @nirmishsingla, Dr. Jeannie Hoffman-Censits, and @BogdanaSchmidt discuss treatment for upper tract urothelial carcinoma (UTUC) using evidence-based medicine. #ONC16 @UroOnc @huntsmancancer @HopkinsMedicine @hopkinskimmel @urotoday @ASCO open.spotify.com/episode/2yNQpS…

What if the key to better cancer outcomes lies in mindfulness, movement, and diet? @virajmaster from @WinshipAtEmory explains in-depth about integrative oncology and survivorship. #ONC15 #holistichealth @EmoryUroOnc @emory_urology @BladderCancerUS @ASCO open.spotify.com/episode/7Imk15…

How can pediatric and adult urologists team up to tackle complex cancer cases? Dr. Amanda Buchanan, @pjhensley11, Dr. Dave Rodeberg discuss interprofessional collaboration in urologic oncology. #ONC14 @UKYurology @urosaltyMD @UKyGenSurgery @ASCO open.spotify.com/episode/4lwSEk…

In Ep. 13, @ejasonabel, Dr. Louis Hinshaw, and @RuchikaTalwarMD explain how urologists and radiologists work together to improve #kidneycancer treatment. #ONC13 @UWiscRadiology @wiscurology @WiscUroOnc @VUMCurology @_backtable @ASCO open.spotify.com/episode/3GRagx…

In our final #HCC case study, we discuss a patient with adrenal metastases after liver transplant. Our panel contemplates different therapies, including tyrosine kinase inhibitors, cryoablation, and SBRT. Stream the entire episode, with all case studies and imaging here:…

Season 2: Genitourinary Cancers-- We're kicking off with a multidisciplinary discussion about #TesticularCancer with @nabiladra, @RichMatulewicz, and @AdityaBagrodia.  Stream here: open.spotify.com/episode/36IFJ3… #ONC12 @IUIntMed @IU_UroOnc @ClintCaryMD @MSKCancerCenter @bbmdmsk…

Drs. Zach Berman, Sid Padia, and Tyler Sandow walk us through an explanation of voxel-based dosimetry for Y90, including key definitions to know and the utility of dose-volume histograms. Stream the full episode here: youtu.be/mtknCLeDAXY Enroll in our free BackTable+…

#Y90 and #Immunotherapy are increasingly being used for a combination approach to treat unresectable #HCC-- In this panel discussion, we discuss optimal timing and dosing for this strategy. Enroll in our free BackTable+ course for CME credits: plus.backtable.com/courses/Multid… #ONC3…

This discussion features a case of diffuse, bilobar #HCC lesions complicated by rupture. Our panel discusses locoregional and systemic therapy options. Stream the entire episode, with all case studies and imaging here: youtu.be/3DLVodvSGFU Enroll in our free BackTable+…

How can we utilize locoregional treatment sand immunotherapies in conjunction to treat HCC? Interventional radiologists and medical oncologists weigh into these decisions Enroll in our free BackTable+ course for CME credits: plus.backtable.com/courses/Multid… #ONC3 @AstraZeneca…

How does Y90 dosimetry change depending treatment intent and #HCC tumor location? Dr. Kirema Garcia-Reyes @kiremagarciamd describes her strategy of selective embolization for multifocal lesions. Stream the full episode here: youtu.be/mtknCLeDAXY Enroll in our free…

This HCC case study involves a large 10cm #HCC lesion and comorbid portal hypertension, which eliminates surgical resection as a treatment option. Our panel discusses the utility of locoregional therapy and potential downstaging for eventual liver transplant. Stream the entire…

Great podcast with my colleague and friend Richard Finn @UCLAHealthJCCC on #HCC #LiverCancer #TACE #Immunotherapy @AASLDtweets @EASLnews @ECIOcongress @SIO_Central @SIRspecialists @YaleCancer @SmilowCancer @Yale_IR

Today on BackTable: For #HCC, there are now multiple phase 3 studies on combination TACE & immunotherapy showing a significant benefit over TACE alone. How do these findings change the treatment algorithm? Drs. Richard Finn and @JuliusChapiro explain. Listen now:…